Association Between Second Progression-free Survival (PFS2) and Overall Survival in Metastatic Castration-resistant Prostate Cancer

David Lorente; Elena Castro; Rebeca Lozano; Javier Puente; Nuria Romero-Laorden; Alejo Rodríguez-Vida; Nuria Lainez; Rosa Villatoro; Casilda Llácer; Carlo Cattrini; Amaia Hernández; Montserrat Domenech; Francisco Zambrana; Elena Almagro; Raquel Luque; Esther Martinez; Fernando López-Campos; Belen Gonzalez; Maria Jose Méndez-Vidal; Ana Medina; Josep Maria Piulats; David Olmos; PROREPAIR-B Study Investigators

doi:10.1016/j.eururo.2020.02.025

Association Between Second Progression-free Survival (PFS2) and Overall Survival in Metastatic Castration-resistant Prostate Cancer

Eur Urol. 2020 Jun;77(6):763-766. doi: 10.1016/j.eururo.2020.02.025. Epub 2020 Mar 3.

Authors

David Lorente¹, Elena Castro², Rebeca Lozano³, Javier Puente⁴, Nuria Romero-Laorden⁵, Alejo Rodríguez-Vida⁶, Nuria Lainez⁷, Rosa Villatoro⁸, Casilda Llácer⁹, Carlo Cattrini¹⁰, Amaia Hernández¹¹, Montserrat Domenech¹², Francisco Zambrana¹³, Elena Almagro¹⁴, Raquel Luque¹⁵, Esther Martinez¹⁶, Fernando López-Campos¹⁷, Belen Gonzalez¹⁸, Maria Jose Méndez-Vidal¹⁹, Ana Medina²⁰, Josep Maria Piulats²¹, David Olmos³; PROREPAIR-B Study Investigators

Affiliations

¹ Servicio de Oncología Médica, Hospital Provincial de Castellón, Castellón de la Plana, Spain; Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain. Electronic address: dlorenteestelles@seom.org.
² Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Genitourinary Cancer Translational Research Group, The Institute of Biomedical Research in Málaga, Málaga, Spain; IBIMA, UGCI Oncología Médica, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain.
³ Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Genitourinary Cancer Translational Research Group, The Institute of Biomedical Research in Málaga, Málaga, Spain.
⁴ Medical Oncology Department, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos, Madrid, Spain.
⁵ Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Hospital Universitario La Princesa, Madrid, Spain.
⁶ Hospital del Mar, Barcelona, Spain.
⁷ Complejo Hospitalario de Navarra, Pamplona, Spain.
⁸ Hospital Universitario Costa del Sol, Marbella, Spain.
⁹ Genitourinary Cancer Translational Research Group, The Institute of Biomedical Research in Málaga, Málaga, Spain; IBIMA, UGCI Oncología Médica, Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Málaga, Spain.
¹⁰ Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Academic Unit of Medical Oncology, IRCCS San Martino Polyclinic Hospital, Genoa, Italy.
¹¹ Onkologikoa-Instituto Oncológico, Donostia, Spain.
¹² Fundació Althaia Manresa, Manresa, Spain.
¹³ Hospital Universitario Infanta Sofía, San Sebastián de los Reyes, Spain.
¹⁴ Hospital Universitario Quirón, Madrid, Spain.
¹⁵ Complejo Hospitalario Universitario de Granada, Granada, Spain.
¹⁶ Hospital Universitario de Jaén, Jaén, Spain.
¹⁷ Prostate Cancer Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain; Hospital Universitario Ramón y Cajal, Madrid, Spain.
¹⁸ Hospital de Son Llatzer, Palma de Mallorca, Spain.
¹⁹ Hospital Universitario Reina Sofía, Córdoba, Spain.
²⁰ Centro Oncológico de Galicia, A Coruña, Spain.
²¹ Institut Catalá d'Oncologia, Hospitalet de Llobregat, Spain.

PMID: 32143923
DOI: 10.1016/j.eururo.2020.02.025

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Male
Neoplasm Metastasis
Progression-Free Survival
Prostatic Neoplasms, Castration-Resistant / mortality*
Prostatic Neoplasms, Castration-Resistant / pathology
Survival Rate